WAM
TMO icon

Wolverine Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Wolverine Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.3K Sell
188
-635
-77% -$305K ﹤0.01% 1176
2026
Q1 		$405K Buy
+823
New +$447K ﹤0.01% 966
2025
Q3 		– Sell
-6,601
Closed -$3.07M – 1832
2025
Q2 		$2.68M Buy
6,601
+4,700
+247% +$1.97M 0.02% 466
2025
Q1 		$946K Sell
1,901
-8,912
-82% -$4.83M 0.01% 704
2024
Q4 		$5.63M Buy
10,813
+3,947
+57% +$2.17M 0.06% 294
2024
Q3 		$4.25M Sell
6,866
-12,178
-64% -$7.21M 0.05% 331
2024
Q2 		$10.5M Buy
+19,044
New +$10.9M 0.12% 185
2024
Q1 		– Sell
-829
Closed -$465K – 1888
2023
Q4 		$440K Sell
829
-5,057
-86% -$2.45M ﹤0.01% 911
2023
Q3 		$2.98M Buy
+5,886
New +$3.14M 0.03% 441
2021
Q2 		– Sell
-1,308
Closed -$596K – 2406
2021
Q1 		$596K Buy
+1,308
New +$624K 0.01% 846
2020
Q1 		– Sell
-310
Closed -$100K – 1696
2019
Q4 		$100K Sell
310
-724
-70% -$220K ﹤0.01% 1083
2019
Q3 		$301K Buy
+1,034
New +$296K ﹤0.01% 896
2016
Q1 		– Sell
-7,747
Closed -$1.1M – 1615
2015
Q4 		$1.1M Buy
7,747
+2,500
+48% +$333K 0.02% 465
2015
Q3 		$641K Hold
5,247
– – 0.02% 617
2015
Q2 		$680K Sell
5,247
-2,600
-33% -$339K 0.02% 552
2015
Q1 		$1.05M Buy
+7,847
New +$1.01M 0.02% 435
2014
Q4 		– Sell
-3,175
Closed -$386K – 2490
2014
Q3 		$386K Sell
3,175
-3,509
-52% -$427K 0.01% 794
2014
Q2 		$788K Buy
6,684
+6,344
+1,866% +$747K 0.02% 474
2014
Q1 		$40K Buy
+340
New +$40.4K ﹤0.01% 1425

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wolverine Asset Management's TMO Position: Q2 2026 in Review

Wolverine Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 77% in Q2 2026, selling an estimated $305K and leaving 188 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Wolverine Asset Management first reported a position in TMO in Q1 2014 and has held it in 19 quarters since. The position peaked at $10.5M in Q2 2024. 2,628 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wolverine Asset Management held 188 shares of Thermo Fisher Scientific worth $94.3K as of Q2 2026.
  • Wolverine Asset Management sold 635 Thermo Fisher Scientific shares in Q2 2026, an estimated $305K.
  • Thermo Fisher Scientific made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1176 holding.
  • Wolverine Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 19 quarters since.
  • Wolverine Asset Management's Thermo Fisher Scientific position peaked at $10.5M in Q2 2024.
  • 2,628 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.